Nasdaq hearing set for Nov 10; bid price compliance regained. Remaining deficiency: market value of listed securities. PrimeC NDS to Health Canada targeted Dec 2026; non-dilutive grant decision expected Q1 2027.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
